Toby Hulf
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- RNA modifications and cancer
- Cancer-related gene regulation
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
Papers in
-
- Genomics and Chromatin Dynamics 3
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 2
- Circular RNAs in diseases 2
- Ubiquitin and proteasome pathways 2
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
- Co-authors
- Susan J. Clark (8 shared papers)Erik D. Wiklund (5 shared papers)Jesper B. Bramsen (3 shared papers)Jørgen Kjems (3 shared papers)Shan Gao (2 shared papers)Aaron L. Statham (3 shared papers)Lars Dyrskjøt (2 shared papers)Clare Stirzaker (3 shared papers)
- Journals
- Oncogene (2 papers)BMC Genomics (1 paper)New Biotechnology (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- AustraliaDenmarkUnited States
In The Last Decade
Toby Hulf
10 papers receiving 987 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 574
- Molecular Biology 883
- Oncology 98
- Aging 6
- Otorhinolaryngology 13
Countries citing papers authored by Toby Hulf
This map shows the geographic impact of Toby Hulf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby Hulf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby Hulf more than expected).
Fields of papers citing papers by Toby Hulf
This network shows the impact of papers produced by Toby Hulf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby Hulf. The network helps show where Toby Hulf may publish in the future.
Co-authors
The 25 scholars most cited alongside Toby Hulf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 317 | |
| 2 | 2012 | 144 | |
| 3 | 2011 | 131 | |
| 4 | 2005 | 85 | |
| 5 | 2012 | 74 | |
| 6 | 2012 | 69 | |
| 7 | 2005 | 64 | |
| 8 | 2011 | 61 | |
| 9 | 2011 | 47 | |
| 10 | 2010 | 10 | |
| 11 | 2023 | 0 |
About Toby Hulf
Toby Hulf is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Rheumatology, having authored 11 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers), Genomics and Chromatin Dynamics (3 papers), RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related gene regulation (2 papers), Circular RNAs in diseases (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (574 citations), Molecular Biology (883 citations), Oncology (98 citations), Aging (6 citations) and Otorhinolaryngology (13 citations). Toby Hulf has collaborated with scholars based in Australia, Denmark and United States. Frequent co-authors include Susan J. Clark, Erik D. Wiklund, Jesper B. Bramsen, Jørgen Kjems, Shan Gao, Aaron L. Statham, Lars Dyrskjøt, Clare Stirzaker, Jenny Z. Song and Torben F. Ørntoft. Their work appears in journals such as Oncogene, BMC Genomics, New Biotechnology, Cancer Epidemiology Biomarkers & Prevention and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.